Where one study disagrees with what other studies report for the same models, and what we are doing to resolve each case.
These are automatic leads, not findings of error. Each release, a check compares how every study ranks the models it shares with other studies. It flags a study that reverses the order the others agree on, or whose gap to a shared reference model lies well outside theirs. Different tasks, populations or metrics often explain a flag.
A flag never hides a result. Flagged results stay in every table, page and download, marked Contested. A result is withheld only when a reviewer marks it disputed.
Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) ranks ESM-1b above VEST4 in 6 of 7 comparisons; 2 of 2 other studies rank VEST4 above ESM-1b.
2 papers rank VEST4 above ESM-1b in 7 of their 10 comparisons and ESM-1b higher in 1; 2 are ties. Livesey and Marsh 2025 ranks ESM-1b above VEST4 in 6 of its 7 comparisons and VEST4 higher in 1.
Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) ranks MutFormer above VEST4 in 6 of 7 comparisons; An openly licensed benchmark and per-gene calibration map for missense pathogenicity predictors on activating cancer drivers ranks VEST4 above MutFormer in 6 of 6 comparisons. No other study gives a verdict, so neither is the outlier.
2 papers rank MutFormer above VEST4 in 6 of their 13 comparisons and VEST4 higher in 7. Of those papers, An openly licensed benchmark… ranks VEST4 higher on its own (6 of 6).